New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
08:02 EDTIGIGI Laboratories announces fourth ANDA submission in 2014
IGI Laboratories announced it has submitted another abbreviated new drug application to the FDA, which brings the company's total number of ANDA submissions in 2014 to four, with fifteen submissions now pending at the FDA.
News For IG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2015
10:00 EDTIGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:31 EDTIGIGI Laboratories upgraded to Buy with $11 target at Roth Capital
Subscribe for More Information
06:14 EDTIGIGI Laboratories upgraded to Buy from Neutral at Roth Capital
July 23, 2015
19:06 EDTIGOn The Fly: After Hours Movers
UP AFTER EARNINGS: Amazon (AMZN), up 17.2%... Marketo (MKTO), up 15.4%... Juniper Networks (JNPR), up 9.9%... NetGear (NTGR), up 9.2%... Qlik Technologies (QLIK), up 9.1%... LogMeIn (LOGM), up 9.9%... Pandora (P), up 10.3%... Mitek Systems (MITK), up 7.8%... Proofpoint (PFPT), up 5.1%... Supreme Industries (STS), up 4.7%... Skyworks (SWKS), up 3.6%... IGI Laboratories (IG), up 3.7%... Maxim Integrated Products (MXIM), up 4.1%... Boyd Gaming (BYD), up 4.1%... Trinity Industries (TRN), up 5%... Trinity Industries (N), up 3.2%... Starbucks (SBUX), up 4.5%. ALSO HIGHER: Qorvo (QRVO), up 2.7% after Skyworks reported quarterly results. DOWN AFTER EARNINGS: TrueCar (TRUE), down 33.1% after reporting quarterly results and cutting fiscal 2015 revenue guidance... Tripadvisor (TRIP), down 9.2%... Align Technology (ALGN), down 7.4%... Capital One (COF), down 4.9%... PMC-Sierra (PMCS), down 9.1%... athenahealth (ATHN), down 2.1%. ALSO LOWER: Sunesis Pharmaceuticals (SNSS), down 59.7% after giving vosaroxin regulatory update... Avalanche Biotechnologies (AAVL), down 5.6% after CEO Thomas Chalberg, Jr., Ph.D. resigns and Hans Hull name interim CEO.
16:38 EDTIGIGI Laboratories sees FY15 revenue $35M-$40M, consensus $38.49M
Subscribe for More Information
16:37 EDTIGIGI Laboratories reports Q2 adjusted EPS (4c), consensus (8c)
Reports Q2 revenue $8.9M, consensus $7.63M.
16:10 EDTIGIGI Laboratories submits sixth ANDA of 2015
IGI Laboratories has submitted its sixth abbreviated new drug application to the FDA of 2015, which brings the company's total number of ANDA submissions now pending at the FDA to twenty-eight.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use